Gram-positive
hydrophobicity-driven
What drove it
- Hydrophobic fraction0.034
- logP0.028
- Morgan fingerprint bit0.022
- GRAVY0.020
- β-sheet fraction0.012
My MEng thesis at NTUA, 2025–2026. I built the whole pipeline: generating new peptides, filtering them and training the models that ranked them. A lab then made the top 15 and tested them.
NTUA Circuits & Systems Group
Houston Methodist Research InstituteMachine Learning–Driven De Novo Antimicrobial Peptide Design Targeting ESKAPE Pathogens
ESKAPE is the six bacteria behind most drug-resistant hospital infections. A lab can make only a handful of new peptides, so I judged the models on the few at the top of their ranking, the only ones that ever get made.
13 of those 15 killed at least one ESKAPE species.
Gram-positive and Gram-negative bacteria are killed in different ways, so each got its own model. Neither was given any rules about how peptides work, and SHAP shows each relying on the features the literature points to: hydrophobicity for Gram-positive, charge and amphipathicity for Gram-negative.
hydrophobicity-driven
What drove it
charge & amphipathicity
What drove it
Models selected on precision in the top 10% of the ranking. Features ranked by mean |SHAP| on the held-out test set.
Each cell is the lowest dose that stopped the bacteria growing, in µg/mL; the brighter the rose, the less it took. Four candidates, GN-3, GN-5, BR-3 and BR-5, cleared four or more species without harming red blood cells.
| Candidate | Ec | Sa | Kp | Ab | Pa | Ef | HL50 |
|---|---|---|---|---|---|---|---|
| Gram-positive-biased | |||||||
| GP-4 | >32 | 4 | >32 | 16 | >32 | 8 | 16† |
| GP-5 | >32 | 8 | >32 | 32 | >32 | 8 | 32 |
| Gram-negative-biased | |||||||
| GN-1 | 16 | 32 | >32 | 8 | >32 | 32 | >32 |
| GN-3 | 16 | 8 | 8 | 8 | >32 | 8 | >32 |
| GN-4 | 32 | >32 | >32 | 8 | >32 | >32 | >32 |
| GN-5 | 32 | 16 | 16 | 4 | >32 | 16 | >32 |
| Broad-spectrum | |||||||
| BR-2 | 32 | 16 | 16 | 32 | >32 | 8 | >32 |
| BR-3 | 16 | 8 | 16 | 16 | >32 | 16 | >32 |
| BR-5 | 16 | 32 | 16 | 16 | >32 | 16 | >32 |
the four best. † toxic at its lowest active dose. No candidate stopped P. aeruginosa, whose outer membrane keeps peptides out; that is the next problem to work on.
90% of each model’s top 10% were active
A lab makes only the first few candidates, so that is the part of the ranking that has to be right.
each model's top driver, by SHAP
Someone has to decide which peptides are worth making, and they need to see why each one ranked high.
5M → 1.45M → 148 → 15 → 13
Every number in the thesis comes from the pipeline’s saved state, and the whole run can be repeated from the start.